In addition, patients with rheumatoid arthritis also need to take methotrexate, which is the basic drug for the treatment of rheumatoid arthritis. Most patients are treated with this medicine in combination with other anti-rheumatic drugs. Patients can also use non-steroidal anti-inflammatory drugs, such as meloxicam, celecoxib and diclofenac sodium. It can quickly relieve the pain symptoms of patients. Rheumatoid arthritis is a chronic disease, which needs long-term drug treatment to control the progress of the disease. Rheumatoid arthritis (RA) is an autoimmune disease that occurs in middle-aged and elderly women. The main clinical feature of RA is repeated intermittent swelling and pain of limbs and joints, accompanied by morning stiffness. The most common parts are interphalangeal joint, metacarpophalangeal joint, wrist joint and knee joint. Laboratory tests showed that ESR was rapid, C-reactive protein was elevated, rheumatoid factor was positive, and anti-CCP antibody was positive.
Drug treatment is the key to rheumatoid arthritis. Oral non-steroidal anti-inflammatory drugs can quickly diminish inflammation, reduce swelling and relieve pain, but these drugs cannot control the progress of rheumatoid arthritis. Immunosuppressants are the key to control the progress of rheumatoid arthritis, such as methotrexate, leflunomide, hydroxychloroquine, sulfasalazine, ilamod, etc. These drugs can fundamentally control the progress of rheumatoid arthritis and inhibit bone destruction. For patients with severe rheumatoid arthritis, biological agents or small molecular targeted drugs can also be used for treatment.